# AVT Natural Products share price today (AVT Natural Products Ltd, NSE: AVTNPL) > AVT Natural Products share price today: ₹96.88 at the NSE close on 3 November 2026, up 30.8% in a year. AVT Natural Products (NSE: AVTNPL) is worth ₹1,476 crore, trades at a P/E of 17.6 and has closed between ₹55.78 and ₹101.00 over the past 52 weeks. > AVT Natural Products Ltd's results are improving, while its P/E is near the low end of its own history over 11 years, higher than only 28% of past readings. AVTNPL · Agricultural Processing - Maize · data as of 3 November 2026. Page: https://www.sectoralpha.in/stocks/avt-natural-products-ltd Sector Alpha also publishes a daily newsletter that explains one Indian stock at a time: https://newsletter.sectoralpha.in/?utm_source=sectoralpha&utm_medium=ai_text&utm_campaign=llms ## Key numbers - Business trend: Mixed, from the last 12 quarters - Price: ₹96.88 (+30.8% in a year) - P/E: 17.6× (lower than 72% of the last 11 years) - Revenue (Jun 2026): ₹241 Cr (+82.6% on a year ago) - Profit (Jun 2026): ₹31.0 Cr (+158.3% on a year ago) - Operating margin: 17.0% (+5.0 points on a year ago) - ROCE: 14%, FY26 - ROIC: 15.2%, against a 12.0% cost of capital: +3.2 points The main question: profits are rising, but only 48% of the last 3 years' profit came in as cash from operations. The gap between reported profit and actual cash is the thing to watch. ## What is the AVT Natural Products share price today? AVT Natural Products Ltd's share price was ₹96.88 at the close on 3 November 2026. It has been rising for 20 weeks. That is 24.9% above its average price over the last 200 trading days. In the last 52 weeks it traded between ₹56 and ₹101, and at that close it sat 91% of the way up from that low. Over the past 13 weeks it has done better than the NIFTY 500, and it has stayed ahead for 14 weeks in a row. Over the last 11 years the share price moved +242% while the NIFTY 500 moved +251%, so it is behind the index over that whole period. The chart above shows the 13-week comparison for every week. This page treats a rise as over when the price closes below its 200-day average on two Fridays in a row. ## What changed at AVT Natural Products this quarter? Three changes stood out: revenue up on a year earlier for 7 quarters in a row, highest quarterly profit in 15 quarters and highest quarterly revenue in 15 quarters. 1. Revenue up on a year earlier for 7 quarters in a row In the June 2026 quarter revenue was ₹241 crore, +82.6% on a year earlier. 2. Highest quarterly profit in 15 quarters Profit of ₹31 crore in the June 2026 quarter is the highest of the last 15 quarters. 3. Highest quarterly revenue in 15 quarters Revenue of ₹241 crore in the June 2026 quarter is the highest of the last 15 quarters. ## What are AVT Natural Products' latest quarterly results? For April to June 2026 (the quarter ended 30 June 2026), AVT Natural Products reported revenue of ₹241 crore, up 82.6% from ₹132 crore a year earlier, and a profit of ₹31.0 crore, up 158.3% from ₹12.0 crore. ### AVT Natural Products results: April to June 2026 against a year earlier | Measure | April to June 2026 | April to June 2025 | Change | | --- | --- | --- | --- | | Revenue | ₹241 crore | ₹132 crore | +82.6% | | Profit | ₹31.0 crore | ₹12.0 crore | +158.3% | | Earnings per share | ₹2.04 | ₹0.80 | +155.0% | | Operating margin | 17.0% | 12.0% | +5.0 points | The next results, for July to September 2026, are due by 14 November 2026: listed companies must publish quarterly results within 45 days of the quarter's end (60 days for the January to March quarter). (From the company's reported quarterly results (quarter ended 30 June 2026). Revenue and profit in ₹ crore.) ## What is the AVT Natural Products share price history? AVT Natural Products closed at ₹96.88 on 3 November 2026, up 30.8% from ₹74.07 a year earlier (31 October 2025) and up 16.7% over five years. Its highest weekly close since March 2016 was ₹131.40 on 1 April 2022. ### AVT Natural Products share price: then and now | When | Close | Change to 3 Nov 2026 | | --- | --- | --- | | 1 week ago · 23 Oct 2026 | ₹87.89 | +10.2% | | 1 month ago · 1 Oct 2026 | ₹87.85 | +10.3% | | 6 months ago · 30 Apr 2026 | ₹69.30 | +39.8% | | 1 year ago · 31 Oct 2025 | ₹74.07 | +30.8% | | 3 years ago · 3 Nov 2023 | ₹90.70 | +6.8% | | 5 years ago · 4 Nov 2021 | ₹83.00 | +16.7% | | 10 years ago · 4 Nov 2016 | ₹34.60 | +180.0% | | Earliest weekly close in our records · 11 Mar 2016 | ₹28.35 | +241.7% | | Highest weekly close since March 2016 · 1 Apr 2022 | ₹131.40 | −26.3% | | Lowest weekly close since March 2016 · 16 Aug 2019 | ₹20.00 | +384.4% | | 52-week high (weekly close) · 16 Oct 2026 | ₹101.00 | −4.1% | | 52-week low (weekly close) · 27 Mar 2026 | ₹55.78 | +73.7% | Weekly closing prices. Each change is the move from that price to the 3 Nov 2026 close. A day's intraday high or low can go beyond these weekly closes. (564 weekly closes from 11 March 2016 to 3 November 2026.) ## What is the latest news on AVT Natural Products? 3 Nov 2026: AVT Natural Products closed at ₹96.88, up 10.2% on the week and up 10.3% on the month. Our read, 10 Oct 2026: The newest quarter combines higher sales with higher operating profit, rather than a flagged exceptional gain. Marigold crop recovery provides a possible operating explanation, while receivables and inventory still tie up cash. ### Earlier - 10 Aug 2026: ex-date for a dividend of ₹0.45 a share. - Results for April to June 2026: Revenue up 82.6% and profit up 158.3% on a year earlier. - 18 Feb 2026: ex-date for an interim dividend of ₹0.35 a share, record date 19 Feb 2026. ### Our read of the business The newest quarter combines higher sales with higher operating profit, rather than a flagged exceptional gain. Marigold crop recovery provides a possible operating explanation, while receivables and inventory still tie up cash. April to June 2026: Sales and operating profit rise together. (Our read after the April to June 2026 results, written 10 October 2026.) ## What dividend does AVT Natural Products pay? AVT Natural Products paid ₹0.80 a share in regular dividends in the 12 months to 4 November 2026 (2 payments), a yield of 0.83% at the ₹96.88 close on 3 November 2026. The last was a dividend of ₹0.45 a share, ex-date 10 August 2026. ### AVT Natural Products dividends since 1 April 2021 | Ex-date | Dividend per share | Type | Record date | | --- | --- | --- | --- | | 10 Aug 2026 | ₹0.45 | Dividend | same day | | 18 Feb 2026 | ₹0.35 | Interim | 19 Feb 2026 | | 6 Aug 2025 | ₹0.40 | Dividend | same day | | 20 Feb 2025 | ₹0.30 | Interim | same day | | 2 Aug 2024 | ₹0.50 | Dividend | n/a | | 22 Feb 2024 | ₹0.30 | Interim | same day | | 18 Aug 2023 | ₹0.60 | Dividend | n/a | | 21 Feb 2023 | ₹0.40 | Interim | same day | | 12 Aug 2022 | ₹0.60 | Dividend | n/a | | 16 Feb 2022 | ₹0.40 | Interim | 17 Feb 2022 | | 17 Aug 2021 | ₹0.40 | Dividend | n/a | Amounts as the company declared them on the NSE. A dividend goes to whoever owns the shares before the ex-date. 5 of 5 Of the last 5 financial years, years with an NSE dividend record Yes. AVT Natural Products Ltd paid out 19% of its profit as dividends in FY26, and it paid a dividend in each of its last 13 reported years. (From the NSE corporate-actions record, read 4 November 2026.) ## What did AVT Natural Products management say on the latest results call? AVT Natural Products' management made 0 promises we could check against what it later reported. (Our read after the April to June 2026 results, written 10 October 2026.) ## What is the future of AVT Natural Products? What is changing in the business? The changes showing up in AVT Natural Products' own numbers are costs spread over more sales. It is too early to say whether they last. Costs spread over more sales too early to call Higher sales are producing more operating profit without a corresponding rise in depreciation. Over the last four quarters, revenue rose from ₹584 crore to ₹821 crore and operating profit from ₹79 crore to ₹114 crore. Why it may last: The figures establish a current benefit, but the sourced extracts do not distinguish structural productivity gains from seasonal demand or a recovery cycle. What could be flattering it: Higher realised prices, seasonal deliveries or delayed customer payments could inflate sales without establishing a durable improvement in the cost base. Next check: September 2026 operating margin stays above September 2025's 9.27%, with operating profit growing faster than revenue and no further deterioration in disclosed collection periods. Quarter by quarter, 4 quarters July to September 2025 Revenue rose from ₹122 crore to ₹160 crore against the same quarter a year earlier, while operating profit rose from ₹8 crore to ₹15 crore. Operating margin improved from 6.57% to 9.27% despite a lower gross margin. Depreciation remained ₹3 crore. The filing confirms the reporting period but gives no explanation of utilisation. ✓ fact From our notes of the call for July to September 2025: The Unaudited Financial Results for the Second Quarter and Half Year ended 30.09.2025. October to December 2025 The annual comparison failed this quarter: revenue increased from ₹173 crore to ₹194 crore, but operating profit fell from ₹30 crore to ₹23 crore. Operating margin fell from 17.30% to 11.91%, alongside gross margin falling from 55.24% to 48.39%. More revenue did not produce better profit absorption. ✓ fact January to March 2026 Revenue increased from ₹157 crore to ₹226 crore and operating profit from ₹25 crore to ₹36 crore. Operating margin edged above the year-earlier 15.67% to 15.76%, despite gross margin slipping from 53.67% to 53.30%. Depreciation fell from ₹4 crore to ₹3 crore. Profit improved, although most of the operating-profit increase followed sales growth. ✓ fact April to June 2026 Revenue increased from ₹132 crore to ₹241 crore and operating profit from ₹16 crore to ₹40 crore against the same quarter a year earlier. Operating margin rose from 12.01% to 16.56%, even though gross margin fell from 55.40% to 47.91%. Depreciation stayed ₹3 crore, consistent with greater sales spreading costs below gross profit. ✓ fact We check 16 kinds of change in every company, such as costs spread over more sales, higher-value products, new orders, new regions or falling debt, against its reported numbers and what management said on its calls. Only changes the numbers back are shown. (Checked against results and calls up to April to June 2026, 10 October 2026.) ## What could change the AVT Natural Products story? What are the risks? A full-year cash-flow statement showing operating cash flow still failing to cover cash capital expenditure despite continued reported profit growth would break the recovery thesis. ### Each change stops working if - Crop-supported operating recovery: Crop availability reverses or operating profit falls while revenue continues growing. - Animal nutrition customer additions: Customer trials fail to become repeat commercial purchases. - Derma-cosmetic commercialization option: Manufacturing and marketing activity fails to produce repeat commercial revenue. ### The main risks - Margin-cycle extrapolation: Recent margins exceed the normalized benchmark. ⚠ estimate - Crop and pricing squeeze: Improved supply does not establish pricing power. ⚠ estimate - Customer concentration: A small customer group can transmit demand changes into sales and collections. ⚠ estimate - Commercialization slippage: Crop-input commercialization still lacks a delivery receipt. ⚠ estimate (Our read after the April to June 2026 results, written 10 October 2026.) ## What to watch in AVT Natural Products' next results? When AVT Natural Products reports July to September 2026, these are the check that show whether the story is still on course. First: September 2026 operating margin stays above September 2025's 9.27%, with operating profit growing faster than revenue and no further deterioration in disclosed collection periods. | What to check | Why | | --- | --- | | September 2026 operating margin stays above September 2025's 9.27%, with operating profit growing faster than revenue and no further deterioration in disclosed collection periods. | Costs spread over more sales | ## Which stock lists is AVT Natural Products on? AVT Natural Products is on 4 of our India lists: Multibagger study list, Undervalued stocks, Momentum stocks and Penny stocks. - [Multibagger study list Study stage: middle](https://www.sectoralpha.in/multibagger-stocks-india) - [Undervalued stocks Profit growth x: 1.537037037037037](https://www.sectoralpha.in/markets/in/deep-value-stocks) - [Momentum stocks Market cap cr: 1438.075819672131](https://www.sectoralpha.in/momentum-stocks-india) - [Penny stocks Earnings growth, 12 months (%): 54.06](https://www.sectoralpha.in/penny-stocks-india) ## Is AVT Natural Products profitable? AVT Natural Products Ltd earned ₹31.0 Cr of net profit in the Jun 2026 quarter, +158.3% on the same quarter a year earlier. That is the 2nd quarter in a row of profit growth. Full-year FY26 profit was ₹65.0 Cr. Over 10 years profit has grown 11.4% a year on average. That is 12.9% of the quarter's revenue. The same quarter a year earlier earned ₹12.0 Cr. For the full year, FY26 profit was ₹65.0 Cr (+35.4% on the year before). Why profit moved: revenue changed +82.6% on a year earlier and the margin moved +5.0 percentage points. Most of the change came from keeping more of each sale. On average over the last four quarters, profit changed +77.3% and revenue +42.4%. Profit is growing faster than sales: fixed costs are spread over more sales, so each extra rupee of revenue adds more to profit. FY26-Q4. revenue ₹226 Cr and profit ₹22 Cr as reported. FY27-Q1. revenue ₹241 Cr and profit ₹31 Cr as reported. Why-sources: our stock research file (10 October 2026) and the company’s own results for those quarters. ## How much revenue does AVT Natural Products make, and is it growing? AVT Natural Products Ltd reported ₹241 Cr of revenue in the Jun 2026 quarter, +82.6% on the same quarter a year earlier. That is the 7th quarter in a row with growth on the year before. Over 10 years it has grown 10.0% a year on average. The last full year, FY26, came in at ₹713 Cr. Why this happened. Product Mix Change is a hypothesis here: customer additions are documented, but incremental profit, commercial scale and cash returns are unknown. No separate margin premium is assigned. The last four reported quarters add to ₹821 Cr. FY26 revenue was ₹713 Cr, +27.5% on the year before. Recent pace: the last four quarters grew +42.4% on average, against 10.0% a year over the longer run, so this year is growing faster than its own long-run rate. Is growth speeding up? Revenue over the last 12 months grew +40.6%, against +25.8% a year over the last 8 quarters (accelerating); profit over the last 12 months grew +53.7%, against +27.6% a year (accelerating). FY26-Q4. revenue ₹226 Cr and profit ₹22 Cr as reported. FY27-Q1. revenue ₹241 Cr and profit ₹31 Cr as reported. Why-sources: our stock research file (10 October 2026) and the company’s own results for those quarters. ## How much of every ₹100 of sales does AVT Natural Products keep? AVT Natural Products Ltd's operating margin was 17.0% in the Jun 2026 quarter, 5.0 percentage points higher than the same quarter a year ago. Across 13 years it has been between 10.0% and 25.0%. The latest quarter is within that range. Why the margin moved: operating margin changed +4.5 percentage points on the year while gross margin changed −7.5 points. So the gain came mostly from the gross margin, which means input costs and prices charged. FY26-Q4. revenue ₹226 Cr and profit ₹22 Cr as reported. FY27-Q1. revenue ₹241 Cr and profit ₹31 Cr as reported. Why-sources: our stock research file (10 October 2026) and the company’s own results for those quarters. ## Is AVT Natural Products' profit turning into cash? Over the last 3 years, 48% of AVT Natural Products Ltd's reported profit came in as cash from its operations, a gap worth watching. In FY26 it brought in ₹12.0 Cr of operating cash against ₹65.0 Cr of profit. After ₹16.0 Cr of spending on assets, free cash was −₹4.0 Cr: it spent more than its operations brought in. Cash-flow figures here are yearly, because quarterly cash statements are not published, so this section changes once a year. Why 48% of profit came in as cash: the cash cycle got 52 days longer between FY21 and FY26, so more of each rupee of profit waits in the business before it arrives. When less than 70% of profit comes in as cash, it is the thing to watch on this page. What to look at next: less of the profit turns into cash than it should, and the cash cycle is 52 days longer. The next section looks at where the cash is stuck. ## Where does AVT Natural Products' cash go? AVT Natural Products Ltd's cash cycle, the days between paying suppliers and getting paid by customers, was 327 days in FY26, up from 275 days in FY21. It spent ₹42.0 Cr on assets over the last 3 years. Customers take 123 days to pay, and stock sits for 348 days on average. At FY26 sales of ₹713 Cr, each day of that cycle ties up about ₹2.0 Cr, so roughly ₹639 Cr is tied up in the business at any time. FY26: customers took 123 days to pay and stock sat for 348 days, about 11.4 months of sales sitting as stock, for a full cycle of 327 days, longer than FY21's 275. The full loop: cash goes out to suppliers and production on day 0. Stock sits for 348 days. Customers pay about 123 days after that. Suppliers are paid at 143 days. Together that makes the 327-day cycle. Spending on assets: ₹42.0 Cr over the last 3 years, against ₹39.0 Cr of depreciation (the yearly wear and tear on existing assets). So it is building a little beyond replacing what wears out. Work still in progress is ₹0.0 Cr (FY26): assets paid for that are not earning yet. In short: cash is getting stuck in the daily cycle, so watch the cycle more than the profit. ## What is AVT Natural Products' P/E ratio, and how does it compare with its own history? AVT Natural Products Ltd's P/E is 17.6×, near the low end of its own history: it has been lower only 28% of the time. Its usual P/E (the middle reading) is 20.0×, over 11 years of weekly prices. This compares the share price with the company’s own past. It does not say what the business is worth. Why the multiple is where it is: over the past year earnings per share moved +34.4% while the price moved +30.8%. Earnings did better than the price, which pulled the multiple down within its own range. Where the price move came from: over 5 years the price moved +3.1% a year; about +9.2% a year came from earnings growth and about −6.1 percentage points from the multiple (the market paying less); over 10 years the price moved +10.8% a year; about +14.6% a year came from earnings growth and about −3.8 percentage points from the multiple (the market paying less). The split is approximate (price return minus earnings growth). It shows how much of the move came from the market paying a different multiple. In short: the multiple is low against its own past, so the earnings trend underneath matters more than the multiple. ## What growth does the AVT Natural Products share price assume? Worked out from its price on 11 October 2026, AVT Natural Products Ltd's share price assumed profit growth of about 10.2% a year. Over the past 10 years its profit actually grew 11.4% a year. Today its P/E is 17.6×, lower than 72% of its own last 11 years. This is a one-day reading, taken on 11 October 2026. Every other number on this page, the multiple included, uses the latest price as of 3 November 2026. A higher price assumes more growth and a lower price less, so it changes whenever the price changes, and this page does not update it between measurements. ## Is the AVT Natural Products business getting better or worse? AVT Natural Products Ltd's business is giving mixed signals. There is no clear direction across the growth lines, with ROCE rising at 21.4%; each line tells part of the story. This is based on 12 quarters of 4 measures. Why it matters: when the lines disagree, each line above matters more than any single label. ## What is the AVT Natural Products story, and has it been checked? AVT Natural Products Ltd's story is not scored yet against the checks our research set on 10 October 2026. Where it sits in its own cycle: EARLY EXPANSION. Still open: A full-year cash-flow statement showing operating cash flow still failing to cover cash capital expenditure despite continued reported profit growth would break the recovery thesis. Our read, 10 October 2026. From the numbers. The authoritative current-segment launch is absent, so the matrix label is taken from this week's… From the price. Price stage 2, week 20, above its 200-day line, relative strength falling. From the research. Where they disagree. That historical-compression classification does not override the normalization result. What is proven. What is not proven yet. A full-year cash-flow statement showing operating cash flow still failing to cover cash capital expenditure despite continued reported profit growth would break the recovery thesis. What would change our mind. A full-year cash-flow statement showing operating cash flow still failing to cover cash capital expenditure despite continued reported profit growth would break the recovery thesis. The test written in advance. A full-year cash-flow statement showing operating cash flow still failing to cover cash capital expenditure despite continued reported profit growth would break the recovery thesis. Measured by: the thesis as written as stated by the next result. The test written in advance. Cash conversion. Measured by: Cash conversion Annual operating cash flow remains below cash capital expenditure. by the next result. The test written in advance. Margin-cycle extrapolation. Measured by: Margin-cycle extrapolation Quarterly operating margin falls below the modeled operating test. by the next result. What the surface reading misses. The surface reading is: The newest quarter appears to show accelerating earnings. The research reads it further: Revenue and operating profit both increased. Unchanged rounded interest and depreciation support an operating explanation, although tax was higher. What the surface reading misses. The surface reading is: Profit growth suggests improving profitability. The research reads it further: Reported operating margin matched the comparison quarter; higher revenue explains most of the operating-profit increase. Sources: our stock research file (10 October 2026) · quarterly results through Jun 2026. The story check is re-scored every results season; the record below never changes. ## What is AVT Natural Products management's track record? Commercial crop-input delivery is unverified and derma-cosmetic wording repeats earlier activity. These are launch delays and missing receipts, not proof of a flagship failure or huge unowned core promise miss; direct through-downturn management evidence remains thin. ### Regulatory and governance record Routine trading-window filings and unrelated US Avnet material are not red flags against AVT. Sources: - [avtnatural.com](https://www.avtnatural.com/wp-content/uploads/2026/07/40th-annual-report-fy-2025-26.pdf) - [nsearchives.nseindia.com](https://nsearchives.nseindia.com/corporate/AVTNPL_21022025151823_AVTNPLDisclosureREG30.pdf) - [choiceindia.com](https://choiceindia.com/stocks/avt-natural-products-ltd-shareholding-pattern) (Checked 14 October 2026.) ## How much does AVT Natural Products earn on its capital? AVT Natural Products Ltd earned a ROCE of 14% in FY26. That is up from a low of 11% in FY19. Its return on capital used (ROIC) is 3.2 percentage points above its cost of capital, so growth here adds value, not just size. It comes from a 9.1% net margin and 0.84× asset turnover (sales divided by assets). Why the return is what it is (FY26): a 9.1% net margin × 0.84× asset turnover × 1.51× leverage (assets divided by equity) ≈ 11.5% on equity. The margin does its share; borrowing plays a small part, so this return is earned, not borrowed. The key test, return on capital used minus the cost of capital: 15.2% − 12.0% = +3.2 percentage points. The 12.0% is a standard assumption for the cost of capital in India, not an estimate for this company. Read the sign and size of the gap, not the decimals. Positive but thin: it creates value with little room for error. The 15.2% ROIC above is the latest reading, as reported. The yearly chart below shows FY26 at 12.6%, and the quarterly chart works out each 12-month window from the quarterly figures, so the readings differ by date, not by method. ## Does AVT Natural Products have too much debt? AVT Natural Products Ltd has total debt of ₹114 Cr against shareholder equity of ₹559 Cr as of Jun 2026, so its debt is 0.20× its equity, which is very little. Year by year, that ratio went from 0.07 in FY22 to 0.20 in FY26. So the returns on this page come from the business, not from borrowed money. Why this happened. Inventory intensity improved, while collections intensity worsened. A cash release requires customer payments and inventory conversion, not merely higher accounting profit. This is a conditional catalyst whose timing is unconfirmed. ## What is the AVT Natural Products shareholding pattern? No group of AVT Natural Products Ltd's owners changed its stake by a full percentage point over the last two years. Foreign institutions moved +0.0 points over the same period, to 0.0%. This uses the four owner groups that companies report every quarter; nothing is guessed between filings. Over the last two years: Promoters: +0.0 points over 8 quarters, to 75.0%; Foreign institutions: +0.0 points over 8 quarters, to 0.0%; Domestic institutions: +0.0 points over 8 quarters, to 0.0%. ## How far is AVT Natural Products from balance-sheet trouble? For AVT Natural Products Ltd, the Z-score is not available, so we say so rather than guess one. It estimates how far the balance sheet is from trouble; it is not a forecast of failure. The debt, cash-flow and return sections show the balance-sheet figures we do have, each with its own date. ## How does AVT Natural Products rank in its industry? 84.3 out of 100, rank 1 of 4 in Agricultural Processing - Maize, with 93% of the evidence available. AVT Natural Products Ltd scores 84.3 out of 100 against the 4 companies it is compared with in Agricultural Processing - Maize, ranking 1. The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. The four parts add up to the total exactly: 32.8 + 13.5 + 18 + 20 = 84.3. This is the same number shown on the industry page; it is worked out once for the whole group and read here. What would change it: The score would fall if profit growth turns negative or margins stop improving while the share price lags its sector. ## Which companies is AVT Natural Products compared with? AVT Natural Products ranks 1 of 4 Agricultural Processing - Maize companies on the 4-Factor Sector Score, with 84.3 out of 100. 1. AVT Natural Products Ltd this page AVTNPL · leader · Sector-leading setup · 93% evidence 84.3 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 32.8/35 · Revenue 40.6% · Profit 53.7% · Operating margin change 5 points · 88% evidence Capital efficiency 13.5/25 · ROCE 14.2% · Operating margin 17% · 100% evidence Valuation 18.0/20 · P/E 16× · PEG 0.48 · 85% evidence Relative strength 20.0/20 · Lead over its industry 20.4% · Lead over NIFTY 500 27.4% · 1 year 18.6% · 100% evidence · 12 of 12 weeks ahead Exact sum: 32.8 + 13.5 + 18 + 20 = 84.3 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 2. [Gujarat Ambuja Exports Ltd](https://www.sectoralpha.in/stocks/gujarat-ambuja-exports-ltd) GAEL · quiet · Evidence leans up · 97% evidence 60.5 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 33.5/35 · Revenue 15.8% · Profit 100% · Operating margin change 9 points · 100% evidence Capital efficiency 11.3/25 · ROCE 12.5% · Operating margin 14% · 100% evidence Valuation 13.5/20 · P/E 12.5× · PEG 1.02 · 85% evidence Relative strength 2.2/20 · Lead over its industry -5.9% · Lead over NIFTY 500 -0.6% · 1 year 31.8% · 100% evidence · 5 of 12 weeks ahead Exact sum: 33.5 + 11.3 + 13.5 + 2.2 = 60.5 · What this means: Earnings are strong; relative strength in its sector is -5.9% and the one-year return is 31.8%. 3. [Sukhjit Starch & Chemicals Ltd](https://www.sectoralpha.in/stocks/sukhjit-starch-chemicals-ltd) SUKHJITS · Evidence leans down · 77% evidence 45.3 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 22.1/43.75 · Revenue -0.8% · Profit 6.3% · Operating margin change 0.8 points · 100% evidence Capital efficiency 10.6/31.25 · ROCE 5.9% · Operating margin 6.8% · 100% evidence Valuation 12.6/25 · P/E 14.6× · PEG 1.5 · 85% evidence Relative strength: no reading this week · its 20 points are shared across the other three Exact sum: 22.1 + 10.6 + 12.6 = 45.3 (no relative-strength reading this week; its 20 points are shared across the other three) · What this means: There is no relative-strength reading for this week, so the score is built from earnings, capital efficiency and valuation alone. 4. [Sanstar Ltd](https://www.sectoralpha.in/stocks/sanstar-ltd) SANSTAR · quiet · Most evidence points down · 61% evidence 34.2 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 14.6/35 · Revenue -0.1% · Profit 63.2% · Operating margin change 8 points · 62% evidence Capital efficiency 6.8/25 · ROCE 5.8% · Operating margin 7.5% · 76% evidence Valuation 10.0/20 · P/E 43.2× · PEG n/a · 0% evidence Relative strength 2.8/20 · Lead over its industry -5.2% · Lead over NIFTY 500 0.5% · 1 year 0% · 100% evidence · 1 of 12 weeks ahead Exact sum: 14.6 + 6.8 + 10 + 2.8 = 34.2 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. Missing figures are not scored as bad. They lower the confidence and pull the final score toward the middle. Relative strength counts only when the company has a reading for this week; with no reading, that factor is left out and its 20 points are shared across the other three in proportion. PEG is not shown when the ratio cannot mean anything: the company must be making a profit, its price-to-earnings must be positive, and its three-year earnings growth must fall between 5% and 60%. Dividing a price multiple by a loss, or by growth measured off a tiny base, produces a number that looks precise and tells you nothing. Under relative strength, one mark per week shows the last 12 weeks: a mark is filled where the company led NIFTY 500 by 5% or more over the 13 weeks ending that week, which is the same test used everywhere on this site. Price stage places the company on the same six-step path the industry is placed on (basing, turning, breaking out, leader, fading, asleep), read from how many weeks running it has led NIFTY 500 and whether that lead is growing or shrinking. It describes where the share price stands, not the direction of earnings, and it is not a recommendation; it is left blank for a company whose weekly history is too short or too stale to read. The figures in this ranking come from the industry comparison: results through the Sep 2026 quarter, and the P/E at that quarter's end. The sections above use the latest weekly price, so a P/E or return there can differ a little from the one here. The stage words in this ranking (such as losing its lead or breaking out) describe the lead over the index, not the price phase in the price section. Related companies: [Agricultural Processing - Maize](https://www.sectoralpha.in/sectors/agricultural-processing-maize), all 4 compared on one page. ## Which companies are close to AVT Natural Products in size? AVT Natural Products is the 3rd largest of 4 Agricultural Processing - Maize companies on Sector Alpha by market value (scores of 30 October 2026). Just above it: Gujarat Ambuja Exports and Sanstar. Just below it: Sukhjit Starch & Chemicals. ### Agricultural Processing - Maize companies close in size 1. [Gujarat Ambuja Exports Ltd](https://www.sectoralpha.in/stocks/gujarat-ambuja-exports-ltd) ₹6,388 crore 2. [Sanstar Ltd](https://www.sectoralpha.in/stocks/sanstar-ltd) ₹1,901 crore 3. AVT Natural Products Ltd ₹1,338 crore 4. [Sukhjit Starch & Chemicals Ltd](https://www.sectoralpha.in/stocks/sukhjit-starch-chemicals-ltd) ₹499 crore [All 4 Agricultural Processing - Maize companies, largest first](https://www.sectoralpha.in/sectors/agricultural-processing-maize#all-companies) ### Companies close in size in other industries 1. [Rico Auto Industries Ltd](https://www.sectoralpha.in/stocks/rico-auto-industries-ltd) ₹1,342 crore · Auto Ancillaries - Spare Parts Accessories 2. [Meghmani Organics Ltd](https://www.sectoralpha.in/stocks/meghmani-organics-ltd) ₹1,339 crore · Pesticides/Agrochemicals 3. AVT Natural Products Ltd ₹1,338 crore 4. [Gala Precision Engineering Ltd](https://www.sectoralpha.in/stocks/gala-precision-engineering-ltd) ₹1,331 crore · Castings, Forgings & Fastners 5. [InfoBeans Technologies Ltd](https://www.sectoralpha.in/stocks/infobeans-technologies-ltd) ₹1,331 crore · IT - Software ## What else do people ask about AVT Natural Products? ### What is AVT Natural Products's share price today? AVT Natural Products Ltd's share price is ₹96.88, +30.8% over the past year. The whole company is worth ₹1,476 Cr on the market. In the last 52 weeks it traded between ₹56 to ₹101; today it is 91% of the way up from the low, 24.9% above its 200-day average (as of 3 November 2026). ### What were AVT Natural Products's latest quarterly results? AVT Natural Products Ltd reported revenue of ₹241 Cr and net profit of ₹31.0 Cr for the Jun 2026 quarter. Revenue rose 82.6% and profit rose 158.3% compared with a year earlier. Earnings per share were ₹2.04. The operating margin was 17.0%, 5.0 percentage points higher than a year earlier (as of 3 November 2026). ### What is AVT Natural Products's market cap? AVT Natural Products Ltd's market capitalisation is ₹1,476 Cr at a share price of ₹96.88. Market cap is the share price times the number of shares, so it changes whenever the price moves (as of 3 November 2026). ### How is AVT Natural Products performing? AVT Natural Products Ltd's share price has been rising for 20 weeks. In its latest quarter, revenue rose 82.6% and profit rose 158.3% compared with a year earlier. Over the past 13 weeks it has done better than the NIFTY 500, for 14 weeks running (as of 3 November 2026). ### Will AVT Natural Products's share price go up? This page does not forecast AVT Natural Products Ltd's share price. What it shows instead: the share price is ₹96.88, and it has been rising for 20 weeks. Its P/E of 17.6× is higher than 28% of its own last 11 years (as of 3 November 2026). ### Where is AVT Natural Products in its business cycle? AVT Natural Products Ltd's FY26 operating margin was 13.0%, against a 13-year range of 10.0% to 25.0%: the low end of its own range, which is often where recoveries start. The latest quarter was 17.0%. Comparing margins with a company's own long history is a good way to see where it is in its cycle (as of 3 November 2026). ### What could break the AVT Natural Products story? The main question: profits are rising, but only 48% of the last 3 years' profit came in as cash from operations. The gap between reported profit and actual cash is the thing to watch. On price, this page treats a rise as over when the share price closes below its 200-day average on two Fridays in a row (as of 3 November 2026). ### Is AVT Natural Products a stock worth studying right now? What the numbers show: AVT Natural Products Ltd's results are improving, while its P/E is near the low end of its own history over 11 years, higher than only 28% of past readings. The main open question: whether the cash starts to follow the profit. Every number on this page is worked out by code from the published figures, with no forecasts and no price opinions (as of 3 November 2026). ### Is there a AVT Natural Products share price forecast for 2026? The changes showing up in AVT Natural Products' own numbers are costs spread over more sales. It is too early to say whether they last. What would change the story: A full-year cash-flow statement showing operating cash flow still failing to cover cash capital expenditure despite continued reported profit growth would break the recovery thesis. ### Where does this page get AVT Natural Products' management information? From AVT Natural Products' results calls, its filings and public records on governance, each dated on the page. Management’s plans are shown as plans, never as results. ## Lists - Multibagger study list: https://www.sectoralpha.in/multibagger-stocks-india - Undervalued stocks: https://www.sectoralpha.in/markets/in/deep-value-stocks - Momentum stocks: https://www.sectoralpha.in/momentum-stocks-india - Penny stocks: https://www.sectoralpha.in/penny-stocks-india This is research, not advice. We’re not SEBI-registered.